UBS Downgrades Chimera Investment to Neutral From Buy, $5 Price Target
MT NewswiresMar 8 23:44
UBS Initiates Coverage On Chimera Investment With Neutral Rating, Announces Price Target of $5.5
BenzingaDec 6, 2023 20:52
Chimera Investment Analyst Ratings
BenzingaDec 6, 2023 20:49
Credit Suisse Maintains Neutral on Chimera Investment, Lowers Price Target to $5.5
BenzingaMay 19, 2023 19:42
What 5 Analyst Ratings Have To Say About Chimera Investment
BenzingaMay 18, 2023 02:01
RBC Capital Maintains Outperform on Chimera Investment, Lowers Price Target to $6
BenzingaMay 17, 2023 20:26
RBC Cuts Price Target on Chimera Investment to $6 From $7, Maintains Outperform Rating
MT NewswiresMay 17, 2023 19:55
Keefe, Bruyette & Woods Maintains Market Perform on Chimera Investment, Lowers Price Target to $5.5
BenzingaMay 9, 2023 21:55
Keefe, Bruyette & Woods Adjusts Price Target on Chimera Investment to $6.25 From $7, Maintains Market Perform Rating
MT NewswiresApr 24, 2023 22:34
Keefe, Bruyette & Woods Maintains Market Perform on Chimera Investment, Lowers Price Target to $6.25
BenzingaApr 24, 2023 19:50
Credit Suisse Sticks to Their Hold Rating for Chimera Investment (CIM)
TipRanksMar 10, 2023 00:31
No Data
No Data